| Project No. |
Project |
Main Project Principal Investigator |
Affiliation |
Execution Period |
AS-BRPT-110-01 |
Glycosidic Switch Liposomes |
Steve Roffler |
Institute of Biomedical Sciences, Institute of Biological Chemistry, Chia Nan University |
2021/1/1~2023/12/31
|
| AS-BRPT-110-02 |
Development of anti- CD33 (Siglec-3) mAb for the treatment of chronic hepatitis B infection and Alzheimer diseases |
Shie-Liang Hsieh |
Genomics Research Center |
2021/1/1~2023/12/31 |
| AS-BRPT-110-04 |
Development of potent and selective inhibitors for targeting galectins-3 and -8 in preclinical trials |
Chun-Hung Lin |
Institute of Biological Chemistry, Institute of Biomedical Sciences, Genomics Research Center |
2021/1/1~2023/12/31 |
| AS-BRPT-110-05 |
Development of Targeted Drug Delivery Systems for Cancer Molecular Imaging and Therapy |
Wen-Shan Li |
Institute of Chemistry, Biomedical Translation Research Center, Taipei Medical University, Tzu Chi Hospital |
2021/1/1~2023/12/31 |
| AS-BRPT-110-06 |
Novel Strategy for Discovery of Inhibitors against Glioblastoma |
Hsing-Pang Hsieh |
Biomedical Translation Research Center, Taipei Medical University |
2021/1/1~2023/12/31 |
| AS-BRPT-110-11 |
Preclinical Studies on New Drugs for Huntington’s Disease (Revised title: Preclinical studies on new drugs for neurodegenerative diseases) |
Yi-Juang Chern |
Institute of Biomedical Sciences, Research Center for Applied Sciences, National Taiwan University |
2020/1/1~2024/12/31 |
| AS-BRPT-111-01 |
Antisense oligonucleotides targeting lncRNAs as therapeutics for amyotrophic lateral sclerosis |
Hung-Chih Kuo |
Institute of Cellular and Organismic Biology |
2022/1/1~2024/12/31 |
| AS-BRPT-113-03 |
Constructing and Prototyping 3D Functional Scaffolds Using Novel in-House-Developed Autopilot Single-Jet Electrospinning Platform for Tissue Engineering and Regenerative Medicine Applications |
Chia-Fu Chou |
Institute of Physics |
2024/1/1~2024/12/31 |
| AS-BRPT-113-05 |
Develop humanized anti-TMCC3 antibody-drug conjugate (ADC) for targeting ovarian cancer stem cell |
Alice L. Yu |
Chang Gung Memorial Hospital |
2024/1/1~2024/12/31 |
| AS-BRPT-110-03 |
Direct Reprogramming of Human Fibroblasts into Retinal Progenitor Cells by Small Molecules to Treat Photoreceptor Degeneration |
Jean Lu |
Genomics Research Center, Tzu Chi Medical Centre |
2021/1/1~2025/12/31 |
| AS-BRPT-112-13 |
Developing humanized antibody targeting pathogenic protein aggregates in ALS |
Yun-Ru Chen |
Genomics Research Center |
2022/1/1~2025/9/30 |
| AS-BRPT-112-01 |
Development of Novel AhR Antagonists for Cancer Immunotherapy via Dendritic Cell Targeting |
Yung-Ling Lee |
Institute of Biomedical Sciences, Genomics Research Center, Taipei Medical University |
2023/1/1~2025/12/31 |
| AS-BRPT-113-01 |
Use a newly established ALS mouse model and iPSCs to develop therapeutic avenues in ALS |
Ya-Ping Yen |
Institute of Molecular Biology |
2024/1/1~2025/12/31 |
| AS-BRPT-113-04 |
Development of bifunctional molecule platform for the treatment of human cancer |
Hsiu-Ming Shih |
Institute of Biomedical Sciences, Research Center for Applied Sciences, National Health Research Institutes, CHANG GUNG MEMORIAL HOSPITAL |
2024/1/1~2025/12/31 |
| AS-BRPT-113-M03 |
Establishment of nucleic acid medicine-based therapy for Wilson’s disease |
Hwai-Jong Cheng |
Institute of Molecular Biology, National Taiwan University |
2024/1/1~2025/12/31 |